HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lydia Lim Selected Research

Giant Cell Granuloma (Peripheral Giant Cell Granuloma)

1/2022Clinical and Radiologic Response of Central Giant Cell Granuloma to Denosumab: A 6-Year Prospective Observational Study.
1/2022Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lydia Lim Research Topics

Disease

2Giant Cell Granuloma (Peripheral Giant Cell Granuloma)
01/2022 - 01/2022
2Melanoma (Melanoma, Malignant)
10/2021 - 01/2021
2Neoplasms (Cancer)
10/2021 - 01/2021
1Breast Neoplasms (Breast Cancer)
10/2021
1Retinoblastoma (Glioblastoma, Retinal)
10/2021
1Heart Failure
12/2014
1Atrial Fibrillation
12/2014

Drug/Important Bio-Agent (IBA)

2DenosumabFDA Link
01/2022 - 01/2022
2Immune Checkpoint InhibitorsIBA
10/2021 - 01/2021
1Cytostatic AgentsIBA
10/2021
1Chimeric Antigen ReceptorsIBA
10/2021
1Immunomodulating AgentsIBA
10/2021
1Hormones (Hormone)IBA
10/2021
1Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1BGP 15IBA
12/2014

Therapy/Procedure

2Immunotherapy
10/2021 - 01/2021
1Therapeutics
01/2021